Recent Finacing
Recent Raise
Syntaxin is a UK biotech developing Targeted Secretion Inhibitor (TSI) biologics that design cell-targeted proteins to selectively inhibit pathological secretion, with programs in acromegaly and chronic pain.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors